SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
1 hedge funds and large institutions have $52K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 297 closing their positions.
100% less funds holding
Funds holding: 298 → 1 (-297)
100% less funds holding in top 10
Funds holding in top 10: 47 → 0 (-47)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $11B
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 297
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Paulson & Co
New York
|
-$950M |
| 2 |
Pentwater Capital Management
Naples,
Florida
|
-$652M |
| 3 |
State Street
Boston,
Massachusetts
|
-$376M |
| 4 |
York Capital Management Global Advisors
New York
|
-$327M |
| 5 |
BlackRock Institutional Trust
San Francisco,
California
|
-$317M |
SLXP Hedge Fund Activity: Q2 2015 in Review
1 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2015, worth a combined $52K — down 100% from $11B a quarter earlier.
Sellers outnumbered buyers: 297 funds closed out of SLXP and 0 opened new positions — a net loss of 297 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Paulson & Co, exiting entirely with an estimated $950M sold.
- 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2015, down from 298 in Q1 2015.
- Funds reported $52K of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2015, down 100% quarter-over-quarter.
- 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2015 and 297 closed out, a net change of -297 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2015 was Paulson & Co, an estimated $950M sold.
Based on aggregated 13F filings for Q2 2015.